The Esophageal Cooling Device gets FDA's rare de novo clearance for innovative devices

Advanced Cooling Therapy's Esophageal Cooling Device has just received the FDA's de novo clearance. That's a strong sign that it's an innovative technology, for the de novo clearance is reserved for low- to moderate-risk devices that don't have a "substantially equivalent" predecessor on the market. The device controls patients' whole-body temperature using temperature modulation equipment that's inserted into the esophagus. More

Suggested Articles

About 10 months after first announcing the move, Google has finally subsumed the healthcare-focused efforts of DeepMind.

Amgen has tapped Adaptive Biotechnologies to deliver next-generation sequencing assays as it moves its blood cancer drugs toward approval.

Bayer led One Drop’s $40 million series B round and licensed its technology for its “bio-digital efforts” in areas such as cancer and heart disease.